The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Understanding why age matters in retirement savings can help you maximize your investments. Learn how to strategize based on your age.
22,430 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Microsoft is transforming an open AI framework into a full blown enterprise tool. Scout harnesses OpenClaw to manage ...
Archer Aviation rode the eVTOL thrill, but reality check milestones have tempered the hype. This guide helps you deci...
Wheels Up Experience is in the spotlight as its stock faces a sharp decline. This article breaks down the primary cau...
host mike rowe slams the college-first script as earnings in the trades rise, with data center electricians pulling i...
A small starter can unlock big, compounding growth. Learn how to pick a durable consumer stock with a $1,000 investme...
When Micron impresses with double-digit growth, it often sets the mood for the broader memory market. This piece brea...
A neighbor’s request to borrow a snowblower tests whether sharing costly equipment makes financial sense. The article...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
If you’re itching to buy your first rental but dread the 20% down barrier, you’re not alone. This guide shares three ...
Young shoppers are driving a tangible-media surge, lifting vinyl and print book sales in the U.S. and U.K. while rede...